Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 November 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 192 pages)

 

Export 12 results:
Author Title [ Type(Asc)] Year
Filters: Author is Gelfand, J. M.  [Clear All Filters]
Journal Article
J. M. Gelfand, Dommasch, E. D., Shin, D. B., Azfar, R. S., Kurd, S. K., Wang, X., and Troxel, A. B., The risk of stroke in patients with psoriasis, J Invest Dermatol, vol. 129, pp. 2411-8, 2009.
J. M. Gelfand, Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., and Troxel, A. B., Risk of myocardial infarction in patients with psoriasis, Jama, vol. 296, pp. 1735-41, 2006.
J. M. Gelfand, Troxel, A. B., Lewis, J. D., Kurd, S. K., Shin, D. B., Wang, X., Margolis, D. J., and Strom, B. L., The risk of mortality in patients with psoriasis: results from a population-based study, Arch Dermatol, vol. 143, pp. 1493-9, 2007.
J. M. Gelfand, Shin, D. B., Neimann, A. L., Wang, X., Margolis, D. J., and Troxel, A. B., The risk of lymphoma in patients with psoriasis, J Invest Dermatol, vol. 126, pp. 2194-201, 2006.
S. K. Kurd, Troxel, A. B., Crits-Christoph, P., and Gelfand, J. M., The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study, Arch Dermatol, vol. 146, pp. 891-5, 2010.
J. M. Gelfand, Weinstein, R., Porter, S. B., Neimann, A. L., Berlin, J. A., and Margolis, D. J., Prevalence and treatment of psoriasis in the United Kingdom: a population-based study, Arch Dermatol, vol. 141, pp. 1537-41, 2005.
N. N. Mehta, Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., and Gelfand, J. M., Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database, Eur Heart J, vol. 31, pp. 1000-6, 2010.
J. M. Gelfand, Berlin, J., Van Voorhees, A., and Margolis, D. J., Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom, Arch Dermatol, vol. 139, pp. 1425-9, 2003.
G. Gupta, Gelfand, J. M., and Lewis, J. D., Increased risk for demyelinating diseases in patients with inflammatory bowel disease, Gastroenterology, vol. 129, pp. 819-26, 2005.
J. D. Lewis, Gelfand, J. M., Troxel, A. B., Forde, K. A., Newcomb, C., Kim, H., Margolis, D. J., and Strom, B. L., Immunosuppressant medications and mortality in inflammatory bowel disease, Am J Gastroenterol, vol. 103, pp. 1428-35; quiz 1436, 2008.
K. Abuabara, Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., and Gelfand, J. M., Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K, Br J Dermatol, vol. 163, pp. 586-92, 2010.
N. N. Mehta, Yu, Y., Pinnelas, R., Krishnamoorthy, P., Shin, D. B., Troxel, A. B., and Gelfand, J. M., Attributable risk estimate of severe psoriasis on major cardiovascular events, Am J Med, vol. 124, pp. 775.e1-6, 2011.
[Page last reviewed 4 November 2019]